Back to top

Bull of the Day

We are upgrading our recommendation on T. Rowe Price Group (TROW) to Outperform from Neutral based on the company's debt-free position and steady profit trend. The company's fourth-quarter 2011 earnings outshined the Zacks Consensus Estimate. Moreover, earnings also compared favorably with the prior-year quarter.

Higher-than-expected top-line growth and increased assets under management (AUM) assisted the improved performance. Furthermore, relative mutual fund performance was also positive. Higher operating expenses were on the downside.

The company has the potential to take advantage of the economic recovery and benefit from the growth opportunities in the domestic and global AUM. Our six-month target price of $70.00 equates to about 20.8x our earnings estimate for 2012. Combined with the $1.36 per share annual dividend, this price target implies an expected return of 13.9% over that period.

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
CTPARTNERS… CTP 13.33 +3.49%
SAIA INC SAIA 45.65 +1.00%
VASCO DATA… VDSI 13.57 +0.67%
AMEDISYS IN… AMED 20.18 +0.10%
FIRSTSERVIC… FSRV 55.66 -0.13%